The impact of low-dose aspirin in the Brain Injury Guidelines on outcomes in traumatic brain injury: A retrospective cohort study.

Background: Current Brain Injury Guidelines (BIG) characterize patients with intracranial hemorrhage taking antiplatelet or anticoagulant agents as BIG 3 (the most severe category) regardless of trauma severity. This study assessed the risk of in-hospital mortality or need for neurosurgery in patients taking low-dose aspirin who otherwise would be classified as BIG 1.

Methods: This was a retrospective study at an academic level 1 trauma center.

Impact of early direct patient care introductory pharmacy practice experiences on student pharmacists' career exploration.

Background And Purpose: The University of Kentucky College of Pharmacy piloted a novel longitudinal introductory experiential program to provide second (P2) and third (P3) year professional students early exposure to pharmacist-provided direct patient care, opportunity to develop professionally expected behaviors, and ability to explore contemporary pharmacy career options. This paper describes the influence of the pilot on pre-advanced pharmacy practice experiences (APPEs) career interests and professional development.

Educational Activity And Setting: Forty P2 and P3 students participated in the longitudinal experiential pilot course.

Epilogue. Establishment of the Center for Chronic Disease Prevention and Health Promotion.

The establishment of the Center for Chronic Disease Prevention and Health Promotion (CCDPHP) at the Centers for Disease Control (CDC) following the Conferences on the State of the Art in Quality Control Measures for Diagnostic Cytology Laboratories is briefly discussed. The CCDPHP is expected to play a major role in the CDC's cancer control program, including participation in establishing effective screening programs and assuring the quality of such methodologies as the Papanicolaou test and mammography.

Measuring screening skills in gynecologic cytology. Results of voluntary self-assessment.

When the Clinical Laboratory Improvement Act (CLIA) was passed in 1967, the Centers for Disease Control (CDC) became interested in evaluating screening performance in cytodiagnosis. Finding no validated performance measurement methods that could be used on a national scale, the CDC initiated a program of sequential investigations to develop information that would describe the state of the art in microscopic performance in gynecologic cytopathology. The first of these experiments developed a method, the Self-Assessment Workshop, to measure performance at the microscope by using sets of glass slides.

Retrospective evaluation of gynecologic cytodiagnosis. II. Interlaboratory reproducibility as shown in rescreening large consecutive samples of reported cases.

Two laboratories exchanged and rescreened a large sample of cases with cervicovaginal smears they had consecutively accessioned to examine the reproducibility of gynecologic cytodiagnosis under optimum conditions. At least a "working agreement" (diagnoses within +/- 1 category on a ten-category scale) was achieved in diagnoses of normal, benign reaction and squamous abnormality (from minimal dysplasia though invasive cancer) in 18,859 cases (96.8%), of endometrial abnormality in 21 cases (42%) and of "unsatisfactory" in 99 cases (20.